A Cell-Cell Communication Marker for Identifying Targeted Tumor Therapies.

Area of Science:

• Cell Biology
• Molecular Oncology
• Pharmacology

Background:

• Gap junction communication is often lost in human cancers, suggesting its role in growth control.
• Connexin proteins form gap junction channels crucial for intercellular communication and potential tumor suppression.

Purpose of the Study:

• Identify bioactive compounds that upregulate gap junction channel-mediated cell-cell communication.
• Investigate signaling pathways modulated by these compounds for targeted anti-tumor therapies.

Main Methods:

• Screened compounds using a fluorescent dye transfer assay to measure cell-cell communication.
• Utilized Western blotting with specific antibodies to monitor protein phosphorylation in signaling pathways.

Main Results:

• Identified chaetoglobosin K (ChK), 4-phenyl-3-butenoic acid (PBA), and PBA methyl ester (PBA-Me) as enhancers of gap junction communication.
• ChK downregulated Akt kinase phosphorylation in the PI3-kinase pathway; PBA/PBA-Me upregulated p38 MAPK phosphorylation.
• ChK and PBA decreased SAPK/JNK activation.

Conclusions:

• Compounds modulating gap junction communication show potential as anti-tumor agents.
• Targeting specific signaling pathways like PI3-kinase and MAPK offers a strategy for cancer therapy.
• Monitoring gap junction intercellular communication is valuable for discovering experimental anti-cancer compounds.